Résultats de la recherche - 6 results
Cervical morbidity in Alsace, France: results from a regional organized cervical cancer screening program.
Alsace before the human papillomavirus vaccinated population reaches the age of screening. Data on cervical lesions and cancers were collected by EVE for the period September 2008 to August 2011 from ...
The use of the permanent sample (eps) to study the returnto- work after cancer. Challenges and opportunities for research
We observe during a five-year period the socio-professional status (inability, disability, unemployment or death) of 645 workers identified in the permanent sample (EPS), having had an oncological ...
Cytological screening for cervical cancer in the province of Limburg, Belgium.
Abstract: Cervical cancer screening in Belgium is mainly opportunistic with periodic attempts to organize it according to the European guidelines. In the province of Limburg (north-east Belgium), a cervical ...
Introduction of human papillomavirus (HPV) vaccination in Belgium, 2007-2008.
2008, the total number of HPV vaccines sold exceeded 530,000 doses. The number of vaccines reimbursed in Belgium, for the period November 2007-November 2008, corresponds to the amount required to fully ...
Description of cervical cancer mortality in Belgium using Bayesian age-period-cohort models.
Publication Type: Peer reviewed scientific article Authors: Raifu, A O; M. Arbyn Source: Archives of Public Health, Volume 67, Issue 3 (2009) Keywords: age-cohort-period modelling Bayesian analysis ...
CanCon European Guide on Quality Improvement in Comprehensive Cancer Control- Chapter 4: Screening
guiding further improvement. Evaluations of the benefit-harm balance and cost-effectiveness of screening are required periodically for existing programmes and prospectively for new screening programmes. ...